1Linnoila RI,Keiser HR,Steinberg SM,et al.Histopathology of benign versus malignant sympathoadrenal paragangliomas:clinicopathologic study of 120 cases including unusual histologic features.Hum Pathol,1990,21(11),1168～1180
2Salmenkivi K,Haglund C,Arola J,et al.Increased expression of tenascin in pheochromocytomas correlates with malignancy.Am J Surg Pathol.2001,25(11),1419～1423
3Thompson LD.Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms:a clinicopathologic and immunophenotypic study of 100 cases.Am J Surg Pathol,2002,26(5),551～66
4Pacak K,Eisenhofer G,Carrasquillo JA,et al.6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma.Hypertension,2001,38(1),6～8
5Nativ O,Grant CS,Sheps SG,et al.The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma.Cancer,1992,69(11),2683～2687
6Kubota Y,Nakada T,Sasagawa I,et al.Elevated levels of telomerase activity in malignant pheochromocytoma.Cancer,1998,82(1),176～9
8Elder EE,Xu D,Hoog A,et al.KI-67 AND hTERT Expression Can Aid in the Distinction between Malignant and Benign Pheochromocytoma and Paraganglioma.Mod Pathol,2003,16(3),246～55
9Favier J,Plouin PF,Corvol P,et al.Angiogenesis and vascular architecture in pheochromocytomas:distinctive traits in malignant tumors.Am J Pathol,2002,161(4),1235～1246
10Zielke A,Middeke M,Hoffmann S,et al.VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.Surgery,2002,132(6),1056～1063
